Based on IP of CAS, e. g. on a 2D CCD camera, Purple Xin Pharmaceuticals, a Ginseng-based company, will diversify into sequencer manufacturing through ist Jilin subsidiary Zhongke Zixin.
China Bio news release, October 30, 2013
CAS Beijing Institute of Genomics and Purple Xin Pharmaceutical Co. will cooperate on 2nd generation DNA sequencer development